以色列料成年人下月底前接种疫苗 4月初重启经济
以色列总理内塔尼亚胡表示,该国目标於所有合资格人士接种新冠疫苗後,在4月5日重启经济,且正与药厂辉瑞(PFE.US)及Moderna(MRNA.US)於当设立基地一事进行商讨。
以色列900万人口中,近半已接种最少一剂疫苗。当地周日(21日)重开商业活动,包括允许店铺及商场营业,部分休闲设施开放予已接种疫苗人士或确诊後康复者。不少学童已回校上课,食肆则允许提供外卖服务。
内塔尼亚胡表示,所有16岁或以上合资格人士料於3月底完接种疫苗,使4月5日全面重启经济得以实现。他又指,将建立两间厂房,使以色列参与全球疫苗供应链,其中Moderna会设厂,辉瑞则设置研发中心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.